.Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AC21_Ulobetasol.Ulobetasol .Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AC21_Ulobetasol.Ulobetasol| name: | Ulobetasol | |
| ATC code: | D07AC21 | |
| route: | topical | |
| compartments: | 1 | |
| dosage: | 0.05 | mg |
| volume of distribution: | 5 | L |
| clearance: | 15 | L/h |
| other parameters in model implementation | ||
Ulobetasol (also known as halobetasol) is a super high-potency topical corticosteroid used for the treatment of corticosteroid-responsive dermatoses, such as plaque psoriasis. It reduces inflammation, itching, and redness. It is typically used as a short-term therapy due to the potential for systemic and local side effects with prolonged use. Ulobetasol is approved for topical application in adults.
No published clinical pharmacokinetic studies reporting quantitative plasma PK parameters or compartmental model of ulobetasol in humans are available; PK profile is estimated based on drug class, route, and FDA label statements.